Phlow-United States Pharmacopeia Plan Richmond, Virginia, Joint Medical Research Venture

SourceArea Development
Date Published02/25/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Domestically, the work will be done:In-house
City reshored to:Richmond
State(s) reshored to:VA
If relevant, work nearshored to:-
Product(s) reshoredactive pharmaceutical ingredients, essential meds
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability
What domestic positive factors made reshoring more attractive?Automation/technology, Customization/Flexibility, Eco-system synergies, Government Incentives, Higher productivity, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D), essential product
Government Incentive dollar amount:partnership
Find Reshoring Articles